High, intermittent dose of all-trans retinoic acid in combination with alpha-interferon for advanced multiple myeloma

Haematologica. 2001 Jul;86(7):776-7.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / toxicity
  • Female
  • Humans
  • Interferon-alpha / administration & dosage*
  • Interferon-alpha / toxicity
  • Male
  • Middle Aged
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Salvage Therapy
  • Treatment Failure
  • Tretinoin / administration & dosage*
  • Tretinoin / toxicity

Substances

  • Interferon-alpha
  • Tretinoin